TrialHuman vaccines & immunotherapeutics2023

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox.

Noriko Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.